Skip to content

PHARMAVANTY

Active Private limited companyfounded 2020active for 6 yearsZevenhoek 12, 9400 NinoveKBO/BCE: BE 0752.751.474

Lifetime

6 annual accounts with figures on one time axis
peak of €45,212 in 2025
€45,212▲ 65.3%
peak of €27,246 in 2023
€25,820▲ 82.1%
peak of €75,144 in 2024
€28,820▼ 61.6%
€6,026▼ 66.6%
Documentsfilings and deeds
31-08-202631 days late
2025micro format
Gross margin from €27,360 to €45,212Result from €14,177 to €25,820Dividend €72,144Equity from €75,144 to €28,820Debts from €18,029 to €6,026Cash from €61,842 to €6,951

Key points

from the 2025 annual accounts

Equity

€28,820 ▼ 61.6%
75,1442024+25,820Profit-72,144Dividend28,8202025

PHARMAVANTY paid out €72,144 in dividends. That is 279% of the 2025 profit.

Filings

6 annual accounts 5 late
AprilJune31 JulyOctober202020222024

The 2024 accounts came in latest, 31 days after the end of the period.

Position in the sector

82.7%

Higher solvency than 89% of companies in retail trade. The sector median is 33.2%, over 25,428 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 26,977 companies had the same profile as PHARMAVANTY has now. Each dot stands for 68 companies, two years later.

94.9%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 26,977 companies, not a prediction for PHARMAVANTY. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

  • 100 sharesdeed of 21-08-2020
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0752751474
Incorporation Founding capital of €3,000, 100 shares · Founded by (comparant oprichter) · appointed as director · published on 21-08-2020 · Gazette deed
First establishment Zevenhoek 12, Ninove
All 11 events

Comparable companies

same main activity, similar in size and age
Company
PHARMAVANTY Ninove €34,846 €45,212 82.7% -
WE FARMA Oosterzele €39,748 €46,689 1.3% -
Custers Elke Maaseik €47,233 €31,315 76.8% -
VANFLETEREN PIETER Antwerp €52,894 €36,548 69.8% -
Astrid Fivez Destelbergen €52,168 €29,879 4.0% -
Sevens Elise Wetteren €53,817 €64,930 6.0% -
Adkg Brussels €43,380 €28,317 47.1% -

These companies have the same main activity as PHARMAVANTY: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €39,700 and €53,800, founded between 2018 and 2022.

Official details

Source: KBO
Status
Active since 19-08-2020Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment unit
2.306.126.6969400 Ninove, since 19-08-2020
Financial year end
31 December
Peppol
Reachable since 29-12-2025
Company details

Annual accounts 2025

≈ €210,000estimated
€34,846▼ 62.6%
Filing
Filed on 31-08-2026
Financials

Insights on PHARMAVANTY

PHARMAVANTY files the micro format. That format states no turnover. The gross margin rose from €10,310 in 2020 to €45,212 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PHARMAVANTY

What is the company number of PHARMAVANTY?
The company number of PHARMAVANTY is 0752.751.474. The VAT number is the same number with BE in front: BE 0752.751.474.
Where is PHARMAVANTY based?
The registered office is at Zevenhoek 12, 9400 Ninove.Company details
What does PHARMAVANTY do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of PHARMAVANTY?
PHARMAVANTY is a private limited company (BV).
When was PHARMAVANTY founded?
PHARMAVANTY was founded on 19-08-2020.
Is PHARMAVANTY still active?
Yes, PHARMAVANTY is an active enterprise in the KBO register.
What is the turnover of PHARMAVANTY?
The turnover in financial year 2025 is about €210,000. This figure is estimated from the gross margin of €45,212 and 56 comparable companies (NACE 477). It probably lies between €110,000 and €370,000.Financials
Is PHARMAVANTY profitable?
In financial year 2025, PHARMAVANTY made a profit of €25,820.
Where can I find the annual accounts of PHARMAVANTY?
PHARMAVANTY filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARMAVANTY due?
PHARMAVANTY must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.